On the other hand, although COX-2 selective inhibitors attenuate inflammation and suppress oncogenesis, their clinical use is connected with potential side effects, most remarkably those within the cardio-cerebrovascular system, including arterial hypertension, myocardial infarction, and stroke [147]. The gene discussed is PTGS2; the disease is Hypertension.